Clinical Trial Update: Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opioid Receptors in Brain Following Oral Dosing [Phase 1]

View source ↗

Summary

Phase 1 PET imaging trial evaluating CVL-354 target occupancy at kappa and mu opioid receptors in the brain after oral dosing; study in opioid use disorder has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• CVL-354

Snippet

Sponsor: Cerevel Therapeutics, LLC | Conditions: Opioid Use Disorder | Phase 1 | Status: COMPLETED